Skip to main content
Top
Published in: Cancer Chemotherapy and Pharmacology 2/2021

01-08-2021 | Correction

Correction to: Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-α and translocating PKC-δ

Authors: Xian-Ming Zhang, Jia Chen, Yu-Gui Xia, Qiang Xu

Published in: Cancer Chemotherapy and Pharmacology | Issue 2/2021

Login to get access

Excerpt

In the original publication of the article, there were several inadvertent errors in the Fig. 9a, b and Fig. 10c, d. The corrected Figs. 9 and 10 are given below.
Metadata
Title
Correction to: Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-α and translocating PKC-δ
Authors
Xian-Ming Zhang
Jia Chen
Yu-Gui Xia
Qiang Xu
Publication date
01-08-2021
Publisher
Springer Berlin Heidelberg
Published in
Cancer Chemotherapy and Pharmacology / Issue 2/2021
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-021-04287-1

Other articles of this Issue 2/2021

Cancer Chemotherapy and Pharmacology 2/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine